This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Baxter Healthcare Sa, Baxter International Inc., The University of Texas System. Active years: 2014.
Company Filing History:
1 out of 1,198 
1 out of 2,530 
1 out of 5,622 
Years Active: 2014
Title: Monte S Willis: Innovator in Cardiac Treatment
Introduction
Monte S Willis is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of cardiac treatment through his innovative research and patented inventions. His work focuses on the development of pharmaceutical compositions aimed at treating cardiac dysfunction.
Latest Patents
Monte S Willis holds a patent titled "Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factor." This patent includes several embodiments, such as a pharmaceutical composition that contains a therapeutically effective amount of at least one anti-MIF antibody and a pharmaceutically acceptable carrier. Other embodiments involve anti-CD74 and anti-TNFR antibodies, which are also included in the pharmaceutical compositions. The patent outlines methods for treating or preventing cardiac dysfunction, improving cardiac function after acute myocardial infarction, and identifying MIF inhibitors.
Career Highlights
Throughout his career, Monte S Willis has worked with prominent organizations, including Baxter Healthcare and The University of Texas System. His experience in these institutions has contributed to his expertise in the field of cardiac treatment and innovation.
Collaborations
Monte has collaborated with notable individuals such as Brett P Giroir and Vidal F De La Cruz, Jr. These collaborations have further enhanced his research and development efforts in the medical field.
Conclusion
Monte S Willis is a distinguished inventor whose work in cardiac treatment has the potential to significantly impact patient care. His innovative approaches and patented methods demonstrate his commitment to advancing medical science.